TNFRSF10A
Tumor necrosis factor receptor superfamily member 10A
Also known as: Apo2, CD261, DR4, TR10A_HUMAN, TRAILR-1, TRAILR1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00220
- Gene
- TNFRSF10A
- Ensembl
- ENSG00000104689
- Chromosome
- 8
- Canonical length
- 468 aa
- Protein class
- Cancer-related genes, CD markers, Predicted membrane proteins
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL), and thus transduces cell death signal and induces cell apoptosis. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
468 residues, UniProt reviewed canonical sequence.
>O00220|TNFRSF10A
1 MAPPPARVHL GAFLAVTPNP GSAASGTEAA AATPSKVWGS SAGRIEPRGG GRGALPTSMG
61 QHGPSARARA GRAPGPRPAR EASPRLRVHK TFKFVVVGVL LQVVPSSAAT IKLHDQSIGT
121 QQWEHSPLGE LCPPGSHRSE HPGACNRCTE GVGYTNASNN LFACLPCTAC KSDEEERSPC
181 TTTRNTACQC KPGTFRNDNS AEMCRKCSRG CPRGMVKVKD CTPWSDIECV HKESGNGHNI
241 WVILVVTLVV PLLLVAVLIV CCCIGSGCGG DPKCMDRVCF WRLGLLRGPG AEDNAHNEIL
301 SNADSLSTFV SEQQMESQEP ADLTGVTVQS PGEAQCLLGP AEAEGSQRRR LLVPANGADP
361 TETLMLFFDK FANIVPFDSW DQLMRQLDLT KNEIDVVRAG TAGPGDALYA MLMKWVNKTG
421 RNASIHTLLD ALERMEERHA REKIQDLLVD SGKFIYLEDG TGSAVSLELocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNFRSF10A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 13 nTPM
- lymph node: 13 nTPM
- urinary bladder: 10 nTPM
- appendix: 9.3 nTPM
- bone marrow: 8.8 nTPM
- esophagus: 8.1 nTPM
Single-cell type
- suprabasal keratinocytes: 63 nCPM
- ocular epithelial cells: 61 nCPM
- basal keratinocytes: 59 nCPM
- vascular endothelial cells: 53 nCPM
- endometrial luminal cells: 51 nCPM
- b-cells: 51 nCPM
Immune cell
- T-reg: 21 nTPM
- naive B-cell: 19 nTPM
- memory CD4 T-cell: 16 nTPM
- naive CD4 T-cell: 16 nTPM
- memory B-cell: 15 nTPM
- MAIT T-cell: 14 nTPM
Brain region
- thalamus: 6.4 nTPM
- medulla oblongata: 6.1 nTPM
- pons: 5.8 nTPM
- midbrain: 5.1 nTPM
- spinal cord: 5.1 nTPM
- cerebral cortex: 4.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.56
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.65
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation of NF-kappaB-inducing kinase activity
- apoptotic process
- cellular response to mechanical stimulus
- extrinsic apoptotic signaling pathway
- extrinsic apoptotic signaling pathway via death domain receptors
- positive regulation of apoptotic process
- signal transduction
- TRAIL-activated apoptotic signaling pathway
Molecular functions
- death receptor activity
- identical protein binding
- protease binding
- signaling receptor activity
- TRAIL binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TNFRSF10A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNFRSF10A as an antibody target. Whether an autoantibody or antibody against TNFRSF10A could matter depends on whether native TNFRSF10A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNFRSF10A is annotated at the cell surface, where native TNFRSF10A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TNFRSF10A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...